SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Maxygen, Inc. Announces Biomedical Advanced Research and Development Authority (BARDA) Decision Not to Award Contract for Development of MAXY-G34 for Acute Radiation Syndrome